Brief: Oncolytics Biotech Promotes Thomas Heineman To Chief Medical Officer
21/12/2021 12:26
Dec 21 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® PROMOTES THOMAS C. HEINEMAN, M.D.,
PH.D., TO
CHIEF MEDICAL OFFICER
Source text for Eikon: ID:nCNWbdq0Ha
Further company coverage: ONC.TO
((reuters.briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer